Condition: Arterial Stiffness · Sponsor: Institut National de la Santé Et de la Recherche Médicale, France
The main objectives of PPS3-2 are (i) to describe the dynamics of vascular aging and baroreflex sensitivity 12 to 16 years a part, (ii) to identify their determinants, and (iii) to quantify the subsequent risk of cardiovascular diseases.
This description comes directly from the study's public registry record.
Jean-Philippe Empana, MD, PhD · 33153988020 · jean-philippe.empana@inserm.fr
Xavier Jouven, MD, PhD · xavier.jouven@inserm.fr
Always discuss trial participation with your own doctor first.
| Centre d'Investigation Précliniques | Paris, France | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06079424